LYTIR

Company · ABBV

AbbVie Inc.

Nasdaq's symbol directory lists ABBV on the New York Stock Exchange as “AbbVie Inc. Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 2 occasions ($20.1M); 3 planned-sale notices; 11 congressional trade disclosures; 10 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 29

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $20.1M in total.Aug: Insider sales $8.2MNov: Insider sales $11.9MDecJanFebMarAprMayJunJulAugSepOctNov$11.9M
Insider purchases above the line: $0Insider sales below: $20.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Jeffrey R. Stewart, EVP, CHIEF COMMERCIAL OFFICER sold on 1 day latest Nov 9, 2026 sold $11.9M
  2. Donoghoe Nicholas, EVP, CHIEF BUS/STRAT OFFICER sold on 1 day latest Aug 14, 2026 sold $8.2M
Every trade (2)
  1. SELLJeffrey R. Stewart, EVP, CHIEF COMMERCIAL OFFICER sold Nov 9, 2026 40,619 shares filing $11.9M
  2. SELLDonoghoe Nicholas, EVP, CHIEF BUS/STRAT OFFICER sold Aug 14, 2026 32,710 shares filing $8.2M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. AZITA SALEKI-GERHARDT filed Nov 16, 2026 Officer 13,481 shares planned sale date 11/16/2026 filing $4.0M
  2. JEFFREY R STEWART filed Nov 9, 2026 Officer 40,619 shares planned sale date 11/09/2026 filing $11.9M
  3. NICHOLAS DONOGHOE filed Aug 14, 2026 Officer 32,710 shares planned sale date 08/14/2026 filing $8.2M

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Pete Sessions (R-TX17): Sale Sep 14, 2026 reported Sep 18, 2026 one of 2 trades the member reported that day House Stocks (including ADRs) $15,001 - $50,000
  2. Rohit Khanna (D-CA17): Purchase Jun 2, 2026 reported Jul 6, 2026 one of 375 trades the member reported that day House owner: dependent $1,001 - $15,000
  3. Rohit Khanna (D-CA17): Purchase May 15, 2026 reported Jun 9, 2026 one of 504 trades the member reported that day House owner: spouse $15,001 - $50,000
  4. Josh Gottheimer (D-NJ05): Sale May 5, 2026 reported Jun 3, 2026 one of 21 trades the member reported that day House Stocks (including ADRs) owner: joint $1,001 - $15,000
  5. Rohit Khanna (D-CA17): Sale Apr 13, 2026 reported May 11, 2026 one of 348 trades the member reported that day House owner: spouse $15,001 - $50,000
  6. Rohit Khanna (D-CA17): Sale Mar 30, 2026 reported Apr 7, 2026 one of 274 trades the member reported that day House owner: dependent $15,001 - $50,000
  7. Alan Armstrong (R-OK): Purchase Mar 27, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $15,001 - $50,000
  8. Rohit Khanna (D-CA17): Sale Jan 29, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: spouse $15,001 - $50,000
  9. Rohit Khanna (D-CA17): Purchase Jan 23, 2026 reported Feb 6, 2026 one of 878 trades the member reported that day House owner: dependent $1,001 - $15,000
  10. Julie Johnson (D-TX32): Sale Dec 18, 2025 reported Jan 15, 2026 one of 62 trades the member reported that day House Stocks (including ADRs) owner: joint $1,001 - $15,000
  11. Julia Letlow (R-LA05): Sale Dec 8, 2025 reported Jan 13, 2026 one of 224 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000

Executive branch · OGE Form 278-T

Reported by the President

14 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports

  1. Purchase: ABBVIE INC Jul 31, 2026 reported Sep 8, 2026 President Donald J. Trump Periodic Transaction Report 09.08.26 $50,001 – $100,000
  2. Purchase: ABBVIE INC Jul 23, 2026 reported Sep 8, 2026 President Donald J. Trump Periodic Transaction Report 09.08.26 $50,001 – $100,000
  3. Purchase: ABBVIE INC Jun 23, 2026 reported Aug 12, 2026 President Donald J. Trump Periodic Transaction Report 08.12.26 $1,001 – $15,000
  4. Purchase: ABBVIE INC Jun 16, 2026 reported Aug 12, 2026 President Donald J. Trump Periodic Transaction Report 08.12.26 $50,001 – $100,000
  5. Sale: ABBVIE INC May 18, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $100,001 – $250,000
  6. Sale: ABBVIE INC May 18, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $1,001 – $15,000
  7. Purchase: ABBVIE INC May 15, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $50,001 – $100,000
  8. Sale: ABBVIE INC May 11, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $1,001 – $15,000
  9. Sale: ABBVIE INC Apr 28, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $1,001 – $15,000
  10. Sale: ABBVIE INC Apr 27, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (1) $100,001 – $250,000

Showing the latest 10 of 14.

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Departure or appointment of directors or officers filing Nov 2, 2026
  2. Results of operations and financial condition filing Oct 30, 2026
  3. Departure or appointment of directors or officers filing Oct 15, 2026
  4. Results of operations and financial condition filing Oct 5, 2026
  5. Regulation FD disclosure filing Sep 3, 2026
  6. Other events filing Aug 18, 2026
  7. Other events filing Aug 5, 2026
  8. Results of operations and financial condition filing Jul 31, 2026
  9. Results of operations and financial condition filing Jul 6, 2026
  10. Regulation FD disclosure filing Jun 22, 2026

Lobbying · Senate LDA reports

Lobbying filed

32 quarterly lobbying reports for 2026 naming AbbVie Inc. as the client: 3 filed by the company itself, 29 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.

  1. The company itself Q3 2026 filing $1.1M
  2. WILLIAMS AND JENSEN, PLLC Q3 2026 filing $90K
  3. CHECKMATE GOVERNMENT RELATIONS Q3 2026 filing $90K
  4. CORNERSTONE GOVERNMENT AFFAIRS, INC. Q3 2026 filing $80K
  5. TARPLIN, DOWNS & YOUNG, LLC Q3 2026 filing $60K
  6. MARSHALL & POPP, LLC Q3 2026 filing $60K
  7. FEDERAL STREET STRATEGIES, LLC Q3 2026 filing $50K
  8. W STRATEGIES, LLC Q3 2026 filing $50K
  9. TIBER CREEK GROUP Q3 2026 filing $30K
  10. TIBER CREEK GROUP Q3 2026 filing no amount stated
  11. BAKER & HOSTETLER LLP Q3 2026 filing no amount stated
  12. The company itself Q2 2026 filing $1.2M
  13. WILLIAMS AND JENSEN, PLLC Q2 2026 filing $90K
  14. CORNERSTONE GOVERNMENT AFFAIRS, INC. Q2 2026 filing $80K
  15. TARPLIN, DOWNS & YOUNG, LLC Q2 2026 filing $60K
  16. MARSHALL & POPP, LLC Q2 2026 filing $60K
  17. W STRATEGIES, LLC Q2 2026 filing $50K
  18. FEDERAL STREET STRATEGIES, LLC Q2 2026 filing $50K
  19. WILLIAMS AND JENSEN, PLLC Q2 2026 filing $30K
  20. BAKER & HOSTETLER LLP Q2 2026 filing no amount stated
  21. CHECKMATE GOVERNMENT RELATIONS Q2 2026 filing no amount stated
  22. The company itself Q1 2026 filing $2.1M
  23. CHECKMATE GOVERNMENT RELATIONS Q1 2026 filing $180K
  24. CORNERSTONE GOVERNMENT AFFAIRS, INC. Q1 2026 filing $80K
  25. TARPLIN, DOWNS & YOUNG, LLC Q1 2026 filing $60K

Showing 25 of 32.

Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.